Skip to main content
Log in

Spasmodic dysphonia combined with insufficient glottic closure by phonation

  • Laryngology
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The authors describe the case history of a patient who suffered from symptoms deriving from two different origins. The patient's voice was spasmodic dysphonia-like interrupted and pressed. At the same time, his voice was powerless, too. The reason for this was that besides the spasmodic dysphonia caused by hyperkinesis, an incomplete closure of the vocal cords during phonation in the middle third was present. It was caused by the atrophy of the vocal cords. In order to eliminate the symptoms, initially we injected 25 IU Botox into the left vocal cord transcutaneously under the direction of EMG control. It resulted in a fluent, though breathy voice. In order to manage the closing insufficiency during phonation, we performed lipoaugmentation on the left vocal cord under high-frequency jet anaesthesia. The result of the two-step procedure was a fluent and clear voice. The speech without interruption lasted for 5 months, until the drug was eliminated. Of course, to prolong the result, the Botox injection should be repeated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Dedo HH (1976) Recurrent nerve section for ASD. Ann Otol Rhinol Laryngol 85: 451–459

    CAS  PubMed  Google Scholar 

  2. Berke GS, Blackwell KE, Gerratt BR, Verneil A, Jackson KS, Sercarz JA (1999) Selective laryngeal adductor denevation-reinnervation: a new surgical treatment for ASD. Ann Otol Rhinol Laryngol 108: 227–231

    CAS  PubMed  Google Scholar 

  3. Fritzell B, Feuer E, Haglund S, Knutsson E, Schiratzki H (1982) Experiences with recurrent laryngeal nerve section for spastic dysphonia. Folia Fonatr (Basel) 34: 160–167

    Google Scholar 

  4. Blitzer A, Brin MF, Fahn S, Lange D, Lovelace RE (1986) Botulinum toxin for the treatment of ASD. Laryngoscope 96: 1300–1301

    CAS  Google Scholar 

  5. Ludlow CL (1990) Treatment of speech and voice disorders with botulinum toxin. JAMA 264: 2671–2675

    Article  CAS  PubMed  Google Scholar 

  6. Jankovic J, Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324: 1186–1194

    CAS  PubMed  Google Scholar 

  7. Wendler J, Seidner W, Kittel G, Eysholdt U (1996) Lehrbuch der Phoniatrie und Paedaudiologie. Thieme, Stuttgart, New York, pp 118–125

  8. Hacki T (1999) Tonhöhen-und Intensitaetbefunde bei Stimmgeübten. Vergleichende Sprechstimmfeld-, Rufststimmfeld- und Singstimmfeldmessung. HNO 47: 809–815

    Article  CAS  PubMed  Google Scholar 

  9. Friedrich G (1998) Externe Stimmlippenmedialisation: Funktionelle Ertgebnisse. Laryngo Rhino Otol 77: 18–26

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Z. Kaszás.

Additional information

This paper was presented at the 4th ELS Congress in Brussels, 5–7 September 2002.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaszás, Z., Lichtenberger, G., Mészáros, K. et al. Spasmodic dysphonia combined with insufficient glottic closure by phonation. Eur Arch Otorhinolaryngol 260, 418–420 (2003). https://doi.org/10.1007/s00405-003-0604-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-003-0604-0

Keywords

Navigation